Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
The new deal was built on the successful launch of Halaven and Fycompa in South Africa.
Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.
Breakout Labs has backed over 30 companies since it handed out the first batch of grants in 2012.
Pace Analytical Services has bought Wolfe Laboratories to strengthen its life sciences contract development offerings.
JSR Life Sciences’ parent company will pay NT$12 billion ($400 million) for Crown Bioscience International, boosting its global footprint and CRO offerings.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.
Kentucky-based CRO CTI Clinical Trial and Consulting Services acquires Portuguese counterpart Eurotrials.
The product of a merger of Pluriomics and Axiogenesis, iPSC company Ncardia has signed licensing deals with Roche and Evotec.
ERT has snatched up iCardiac Technologies, which pioneered precision QT studies in early-phase clinical research.
X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.